Q32 Bio Inc.: Boxer Capital Management, LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Boxer Capital Management amended its Schedule 13G filing on Q32 Bio Inc., updating its disclosed stake in the clinical-stage biotech, per SEC accession 0001213900-26-116951. The filing signals a change in the investor's reported position, though the amended document did not specify a revised percentage in the headline disclosure. Schedule 13G amendments are typically watched for shifts in passive or institutional ownership. Investors will look to the full filing for the updated share count and any change in voting authority.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Boxer Capital Management, LLC, Q32 Bio Inc.